Deepak Chadha
Net Worth

Last updated:

What is Deepak Chadha net worth?

The estimated net worth of Mr. Deepak Chadha is at least $2,582,842 as of 19 May 2021. He owns shares worth $183,692 as insider and has received compensation worth at least $2,399,150 in Brickell Biotech, Inc..

What is the salary of Deepak Chadha?

Mr. Deepak Chadha salary is $479,830 per year as Chief R&D Officer in Brickell Biotech, Inc..

How old is Deepak Chadha?

Mr. Deepak Chadha is 55 years old, born in 1970.

What stocks does Deepak Chadha currently own?

As insider, Mr. Deepak Chadha owns shares in one company:

Company Title Shares Price per share Total value
Brickell Biotech, Inc. (BBI) Chief R&D Officer 78,167 $2.35 $183,692

What does Brickell Biotech, Inc. do?

Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. The company was founded in 2009 and is headquartered in Boulder, Colorado.

BBI logo
BBI
Brickell Biotech, Inc.
$2.35

Deepak Chadha insider trading

Brickell Biotech, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 12,500 $0.83 $10,375
Purchase
Common Stock 2,700 $0.82 $2,211
Option
Restricted Stock Units 25,000 N/A N/A
Option
Common Stock 25,000 N/A N/A
Purchase
Common Stock Warrants (right to buy) 26,087 $1.25 $32,609
Purchase
Common Stock 26,087 $1.25 $32,609

Brickell Biotech key executives

Brickell Biotech, Inc. executives and other stock owners filed with the SEC:

  • Attorney Robert Busard Brown (63) Chief Executive Officer & Director
  • Mr. Andrew D. Sklawer (40) Co-Founder, Chief Operating Officer & Sec.
  • Mr. Deepak Chadha (55) Chief R&D Officer
  • Mr. Reginald L. Hardy M.B.A., R.Ph. (67) Co-Founder & Chairman